SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001677301-16-000007
Filing Date
2016-12-20
Accepted
2016-12-20 18:26:21
Documents
1
Period of Report
2016-12-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 3628
  Complete submission text file 0001677301-16-000007.txt   5215
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 109 BRIERY BRANCH COURT MORRISVILLE NC 27560
Business Address
Whitaker Anne Clem (Reporting) CIK: 0001593283 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-14956 | Film No.: 162062389